[ad_1]
The Ministry of Health reported 3,555 new cases of coronavirus and 106 deaths. The Ministry of Health assured that people who already gave them coronavirus will be vaccinated. In addition, the FDA approved the emergency use of the Janssen single-dose vaccine.
Today, Sunday, February 28, 2021, the Ministry of Health reported 3,555 new cases of coronavirus and 106 deaths. With these figures, the country reaches a total of 2,251,690 confirmed cases since the pandemic began and 59,766 deaths. The number of people recovered is 2,148,249. (Read: Coronavirus in Colombia today February 27: figures, vaccinated and main news)
In addition, the country has 1,491 conglomerates. These are the territories: Amazonas, Antioquia (Ituango), Arauca, Atlántico, Barranquilla, Bogotá, Boyacá, Bolívar, Buenaventura, Caldas, Caquetá, Cartagena, Casanare, Cauca, Cesar, Chocó, Córdoba, Cundinamarca, Huila, La Guajira, Magdalena , Meta, Nariño, Norte de Santander, Putumayo, Quindío, Risaralda, San Andrés, Santa Marta, Santander, Sucre, Tolima, Valle, Vaupés, Vichada, Guaviare and Guainía.
Regarding vaccines, the Ministry of Health reported that 130,578 doses have been applied until Sunday, February 28 at 4:00 p.m.
Minsalud says that people who had coronavirus will be vaccinated
The Minister of Health, Fernando Ruiz, explained that people who already had coronavirus will be included in the Vaccination Plan in Colombia. Although at the beginning it was hypothesized that immunity when acquiring the disease was sufficient, after reviewing the scientific evidence, the decision was changed.
After analyzing this evidence, people who tested positive for coronavirus will no longer be immunized when the entire general population has been vaccinated, but after 90 days of being diagnosed with the disease and in the prioritization stage in which it is assigned. (You can read: Invima gives the green light of the AstraZeneca vaccine)
“This decision is made on the recommendation of the scientific advisory committee and taking into account the scientific literature. Those who have been symptomatic are considered to be taken into account from the date of onset of symptoms and in those who have not, from the date of taking the test ”, added Ruiz.
Sputnik Light, Russia’s bet on a one-dose vaccine
Russia is in the race to develop a one-dose COVID-19 vaccine. Recently, the developers of the drug Sputnik V, which is already being distributed in several countries around the world, applied for the registration of the drug Sputnik Light, the single-dose bet. (Read: This is what you need to know to understand the world of vaccines)
“Sputnik V has already submitted an urgent registration request in Russia and other countries for its single-dose Sputnik Light vaccine (…) it goes out to the world in March,” the producers explained through their Twitter account.
According to the company, Sputnik Light, the single-dose drug, has already begun its third phase of clinical trials. Anastasía Rákova, deputy mayor of Moscow, in an interview with the Russian news agency Interfax, “the first participants in the Sputnik Light vaccine research have already been vaccinated. As the volunteers pass the check-ups, the number of vaccinated will increase ”.
FDA clears use of Janssen vaccine
The United States Food and Drug Administration (FDA) has authorized the emergency use of the coronavirus vaccine made by Janssen. This single-dose, refrigerator-safe immunizer is the third to get the green light in the United States, after those from Pfizer and Moderna.
This week, the agency’s vaccine advisory committee had ensured that Johnson & Johnson’s vaccine is safe and effective enough against the SARS-CoV-2 virus among those 18 and older. The tests carried out on this immunizer showed an effectiveness against the coronavirus of 66%, below 94-95% of existing vaccines, but with an 86% capacity to avoid serious cases of the disease, hospitalizations and deaths. , which could be enough to protect the population. (It may interest you: Private individuals can bring vaccines, but not yet (and we don’t know when))
This is the first COVID-19 vaccine that only requires one dose. According to the FDA, “the inclusion of the first single-dose vaccine should help speed up the vaccination campaign by not requiring a second dose at three weeks, as is the case with the Pfizer and Moderna injections, although Johnson & Johnson has pointed out that shuffles possible annual reminders ”.
